Premium
Sutro Biopharma Inc (STRO)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Integrated Core Strategies (US) LLC | Institution | 1 296 078 | 7,82% | US$ 38,30M | 2024-09-30 |
| BVF Partners L.P. | Institution | 1 251 788 | 7,55% | US$ 36,99M | 2026-03-31 |
| Affinity Asset Advisors, LLC | Institution | 1 069 519 | 6,45% | US$ 31,60M | 2026-03-31 |
| Samsara BioCapital LLC | Institution | 1 062 872 | 6,41% | US$ 31,41M | 2026-03-31 |
| Point72 Associates, LLC | Institution | 946 829 | 5,71% | US$ 27,98M | 2026-04-24 |
| Point72 Asset Management, L.P. | Institution | 946 829 | 5,71% | US$ 27,98M | 2026-04-24 |
| Perceptive Advisors LLC | Institution | 898 025 | 5,42% | US$ 26,54M | 2026-04-14 |
| Perceptive Life Sciences Master Fund, Ltd. | Institution | 898 025 | 5,42% | US$ 26,54M | 2026-04-14 |
| Kynam Capital Management, LP | Institution | 872 558 | 5,27% | US$ 25,78M | 2026-03-31 |
| OrbiMed Advisors LLC | Institution | 801 144 | 4,83% | US$ 23,67M | 2026-03-31 |
| Affinity Healthcare Fund, LP | Institution | 748 382 | 4,52% | US$ 22,11M | 2026-01-22 |
| Vanguard Capital Management, LLC | Institution | 720 442 | 4,35% | US$ 21,29M | 2026-03-31 |
| RA Capital Management, L.P. | Institution | 715 307 | 4,32% | US$ 21,14M | 2026-03-31 |
| Eventide Asset Management, LLC | Institution | 715 307 | 4,32% | US$ 21,14M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 668 693 | 4,04% | US$ 19,76M | 2026-02-18 |
| Samsara Opportunity Fund, L.P. | Institution | 643 777 | 3,89% | US$ 19,02M | 2026-02-11 |
| ADAR1 Capital Management, LLC | Institution | 524 441 | 3,16% | US$ 15,50M | 2026-03-31 |
| Velan Capital Partners LP | Institution | 512 160 | 3,09% | US$ 15,13M | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 488 916 | 2,95% | US$ 14,45M | 2026-02-18 |
| Balyasny Asset Management L.P. | Institution | 465 792 | 2,81% | US$ 13,76M | 2026-03-31 |
| Woodline Partners LP | Institution | 457 441 | 2,76% | US$ 13,52M | 2026-03-31 |
| Samsara Biocapital, L.P. | Institution | 419 095 | 2,53% | US$ 12,38M | 2026-02-11 |
| Mr. William Newell | Initiés | 409 056 | 2,47% | US$ 12,09M | 2025-03-31 |
| UBS Asset Management AG | Institution | 392 871 | 2,37% | US$ 11,61M | 2026-03-31 |
| Acadian Asset Management LLC | Institution | 335 813 | 2,03% | US$ 9,92M | 2026-03-31 |
| MRL Ventures Fund LLC | Institution | 272 351 | 1,64% | US$ 8,05M | 2026-03-31 |
| Acuta Capital Partners, LLC | Institution | 269 425 | 1,63% | US$ 7,96M | 2026-03-31 |
| BlackRock, Inc. | Institution | 232 684 | 1,40% | US$ 6,88M | 2026-03-31 |
| Kvp Capital Advisors, LP | Institution | 226 575 | 1,37% | US$ 6,70M | 2026-03-31 |
| Marshall Wace LLP | Institution | 222 634 | 1,34% | US$ 6,58M | 2026-03-31 |
| Millennium Management LLC | Institution | 210 378 | 1,27% | US$ 6,22M | 2026-03-31 |
| Dr. John Freund | Initiés | 200 053 | 1,21% | US$ 5,91M | 2025-03-31 |
| Adage Capital Management, L.P. | Institution | 200 000 | 1,21% | US$ 5,91M | 2026-03-31 |
| Opaleye Management Inc. | Institution | 190 671 | 1,15% | US$ 5,63M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 171 386 | 1,03% | US$ 5,06M | 2026-03-31 |
| Mr. Edward Albini | Initiés | 160 805 | 0,97% | US$ 4,75M | 2025-05-15 |
| Ms. Linda Fitzpatrick | Initiés | 130 127 | 0,79% | US$ 3,85M | 2025-05-01 |
| Citadel Advisors LLC | Institution | 117 537 | 0,71% | US$ 3,47M | 2026-03-31 |
| Renaissance Technologies LLC | Institution | 97 824 | 0,59% | US$ 2,89M | 2026-03-31 |
| Dr. Anne Borgman-Hagey | Initiés | 97 452 | 0,59% | US$ 2,88M | 2025-05-01 |
| Vanguard Fiduciary Trust Company | Institution | 94 838 | 0,57% | US$ 2,80M | 2026-03-31 |
| Susquehanna International Group, LLP | Institution | 84 902 | 0,51% | US$ 2,51M | 2026-03-31 |
| Biotechnology Value Trading Fund OS LP | Institution | 75 359 | 0,45% | US$ 2,23M | 2026-02-18 |
| Eversept Partners, L.P. | Institution | 73 161 | 0,44% | US$ 2,16M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
